ALX Oncology Holdings Inc.ALXONASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P44
Within normal range
vs 3Y Ago
-0.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -11.04% |
| Q3 2025 | 26.97% |
| Q2 2025 | 5.10% |
| Q1 2025 | 23.04% |
| Q4 2024 | -26.28% |
| Q3 2024 | 4.48% |
| Q2 2024 | 29.95% |
| Q1 2024 | 4.42% |
| Q4 2023 | -27.34% |
| Q3 2023 | 1.74% |
| Q2 2023 | -14.00% |
| Q1 2023 | -34.58% |
| Q4 2022 | 33.08% |
| Q3 2022 | -81.69% |
| Q2 2022 | 17.78% |
| Q1 2022 | -18.22% |
| Q4 2021 | 29.64% |
| Q3 2021 | -20.53% |
| Q2 2021 | -301.60% |
| Q1 2021 | 62.28% |
| Q4 2020 | -42.60% |
| Q3 2020 | -54.92% |
| Q2 2020 | 31.24% |
| Q1 2020 | -211.86% |
| Q4 2019 | 9.79% |
| Q3 2019 | 26.39% |
| Q2 2019 | -12.10% |
| Q1 2019 | 0.00% |